152 related articles for article (PubMed ID: 81681)
41. Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation.
Switalska HI; Niewiarowski S; Tuszynski GP; Rucinski B; Schmaier AH; Morinelli TA; Cierniewski CS
J Lab Clin Med; 1985 Dec; 106(6):690-700. PubMed ID: 2415646
[TBL] [Abstract][Full Text] [Related]
42. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
43. Platelet defects in the myeloproliferative disorders.
Inceman S; Tangün Y
Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
[No Abstract] [Full Text] [Related]
44. [Platelet function in chronic myeloproliferative syndromes associated with thrombocytosis].
Grebe G; Pereira J; Mezzano D; Legues ME; Aranda E; Lira P
Rev Med Chil; 1985 Jan; 113(1):32-7. PubMed ID: 4081383
[No Abstract] [Full Text] [Related]
45. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets.
Bautista AP; Buckler PW; Towler HM; Dawson AA; Bennett B
Br J Haematol; 1984 Dec; 58(4):679-87. PubMed ID: 6240280
[TBL] [Abstract][Full Text] [Related]
46. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time.
Baker RI; Manoharan A
Eur J Haematol; 1988 Mar; 40(3):267-72. PubMed ID: 3356243
[TBL] [Abstract][Full Text] [Related]
47. Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy.
Preston FE; Ward JD; Marcola BH; Porter NR; Timperley WR; O'Malley BC
Lancet; 1978 Feb; 1(8058):238-40. PubMed ID: 74664
[TBL] [Abstract][Full Text] [Related]
48. [The measurement of beta-thromboglobulin by enzyme immunoassay technique (author's transl)].
Tanaka M; Hirota Y; Kato K
Rinsho Ketsueki; 1982 Feb; 23(2):150-4. PubMed ID: 6178857
[No Abstract] [Full Text] [Related]
49. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
50. Proceedings: A radioimmunoassay for human platelet beta-thromboglobulin.
Ludlam CA; Bolton AE
Thromb Diath Haemorrh; 1975 Sep; 34(1):349. PubMed ID: 52900
[No Abstract] [Full Text] [Related]
51. In vivo platelet release in myeloproliferative disorders.
Ireland H; Lane DA; Wolff S; Foadi M
Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
[TBL] [Abstract][Full Text] [Related]
52. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
[TBL] [Abstract][Full Text] [Related]
53. Primary thrombocythaemia in childhood.
Linch DC; Hutton R; Cowan D; Moore AR; Richards JD; Wilkinson LS
Scand J Haematol; 1982 Jan; 28(1):72-6. PubMed ID: 7071518
[No Abstract] [Full Text] [Related]
54. Evidence for the platelet specificity of beta-thromboglobulin and studies on its plasma concentration in healthy individuals.
Ludlam CA
Br J Haematol; 1979 Feb; 41(2):271-8. PubMed ID: 85458
[TBL] [Abstract][Full Text] [Related]
55. The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography.
Dapling RB; Snowden JA; West J; Talbot JF; Nelson ME; Greaves M
Clin Lab Haematol; 1996 Dec; 18(4):277-9. PubMed ID: 9054702
[TBL] [Abstract][Full Text] [Related]
56. [Substances released by platelets. 1. beta-TG and PF 4].
Niikura H
Rinsho Byori; 1985 Apr; Spec No 62():46-59. PubMed ID: 2411978
[No Abstract] [Full Text] [Related]
57. Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.
Schafer AI
N Engl J Med; 1982 Feb; 306(7):381-6. PubMed ID: 6799826
[TBL] [Abstract][Full Text] [Related]
58. Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosis.
Dana B; Carvalho AC; Ellman L
Am J Clin Pathol; 1976 Jun; 65(6):964-9. PubMed ID: 945687
[TBL] [Abstract][Full Text] [Related]
59. Thrombocytosis.
Major Probl Intern Med; 1976; 10():46-50. PubMed ID: 785115
[No Abstract] [Full Text] [Related]
60. beta-thromboglobulin and heparin-neutralising activity test in clinical conditions.
Lancet; 1977 May; 1(8022):1153-4. PubMed ID: 68249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
